Suvretta Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Suvretta Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-255,000	Closed	-$1.42M	–	104
2025 Q1	$1.42M	Buy	+255,000	New	+$2.23M	0.06%	82
2023 Q3	–	Sell	-492,924	Closed	-$3.83M	–	100
2023 Q2	$3.83M	Sell	492,924 -1,409,719	-74%	-$8.01M	0.2%	64
2023 Q1	$10.8M	Hold	1,902,643	–	–	0.52%	50
2022 Q4	$11.2M	Hold	1,902,643	–	–	0.47%	50
2022 Q3	$6.09M	Buy	1,902,643 +640,179	+51%	+$2.56M	0.26%	54
2022 Q2	$5.66M	Buy	1,262,464 +821,768	+186%	+$3.28M	0.22%	62
2022 Q1	$2.35M	Hold	440,696	–	–	0.07%	72
2021 Q4	$6.48M	Buy	440,696 +291,596	+196%	+$4.55M	0.13%	70
2021 Q3	$3.12M	Buy	+149,100	New	+$3.02M	0.05%	85
2021 Q1	–	Sell	-252,910	Closed	-$8.56M	–	125
2020 Q4	$8.56M	Buy	+252,910	New	+$7.26M	0.12%	64
2020 Q3	–	Sell	-76,432	Closed	-$2.58M	–	113
2020 Q2	$2.58M	Buy	+76,432	New	+$2.44M	0.06%	67

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return